Drug Discovery Rounds provide opportunities for meetings between our investigators and leaders in the pharma and biotech world.

Via its Drug Discovery Rounds, the Massachusetts General Hospital Division of Clinical Research provides the opportunity for individual meetings between investigators at Mass General and leaders in the pharma and biotech world.

During these face-to-face meetings, a clinical investigator and/or a fundamental science investigator from Mass General will brainstorm about drug discovery opportunities in their field of interest with key advisors in pharma and biotech.

Topics may include how to approach companies, what companies are looking for and conceptual advice about working with pharma and biotech.

Advisors include:

  • Mark Fishman, MD, President of the Novartis Institutes for BioMedical Research
  • Steven Paul, MD, Third Rock Ventures (former President of Eli Lilly Research Labs)
  • David Barlow, Chairman and CEO of Black Diamond Capital, LLC